J. KEVIN BUCHI - 10 Mar 2025 Form 4 Insider Report for Amneal Pharmaceuticals, Inc. (AMRX)

Role
Director
Signature
/s/ Denis Butkovic, Attorney-in-Fact
Issuer symbol
AMRX
Transactions as of
10 Mar 2025
Transactions value $
$0
Form type
4
Filing time
12 Mar 2025, 16:11:47 UTC
Previous filing
03 Mar 2025
Next filing
13 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMRX Class A Common Stock Gift $0 -262,072 -100% $0 0 10 Mar 2025 Direct F1
holding AMRX Class A Common Stock 262,072 10 Mar 2025 By Trust F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On March 10, 2025, reporting person gifted 262,072 shares of Class A Common Stock to a trust for no consideration. The Reporting person is trustee of the trust, and the son of the reporting person is the sole beneficiary.